Showing results (71-80 of 192) with videos related to
Sort By:
Pageof 20
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2019
Heterogeneity in refractory acute myeloid leukemiaSachi Horibata, Gege Gui, Justin Lack, et al.ACS Nano|November 14, 2013
Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein traffickingXue Xue, Matthew D Hall, Qiang Zhang, et al.Molecular Cancer Research : MCR|August 30, 2008
SIRT1 contributes in part to cisplatin resistance in cancer cells by altering mitochondrial metabolismXing-Jie Liang, Toren Finkel, Ding-Wu Shen, et al.Journal of Theoretical Biology|December 3, 2014
Modeling intrinsic heterogeneity and growth of cancer cellsJames M Greene, Doron Levy, King Leung Fung, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 14, 2012
Drug resistance: still a daunting challenge to the successful treatment of AMLBrian C Shaffer, Jean-Pierre Gillet, Chirayu Patel, et al.Cancer Drug Resistance (Alhambra, Calif.)|July 26, 2021
ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an in vivo modelJordan M Hotz, Joanna R Thomas, Emily N Katz, et al.The Journal of Biological Chemistry|December 24, 2002
Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic effluxJohn Golin, Suresh V Ambudkar, Michael M Gottesman, et al.Journal of Inorganic Biochemistry|May 30, 2015
Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patientsMarina Stukova, Matthew D Hall, Samantha D Tsotsoros, et al.Journal of Molecular Biology|August 30, 2008
Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minimaChung-Jung Tsai, Zuben E Sauna, Chava Kimchi-Sarfaty, et al.Molecular Cancer Therapeutics|December 20, 2007
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporterChung-Pu Wu, Suneet Shukla, Anna Maria Calcagno, et al.Pageof 20